All In MedTech

Device Trial Radar · NCT01076218

Navigator 1.5 Accuracy Study

In Clinic Evaluation of the FreeStyle Navigator® Continuous Glucose Monitoring System Version 1.5

Last checked: Nov 20, 2026Latest source record: Jun 17, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

57

Actual

Start

Apr 2008

Primary completion

Jul 2008

Study completion Jul 2008

Sponsor

Lead sponsor
Abbott Diabetes CarePublic (ABT)
Sponsor type
Industry
First posted
Feb 26, 2010

More device trials from this sponsor

Design

Study type
Observational
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of the study is to confirm that the accuracy and safety of Version 1.5 of the FreeStyle Navigator Continuous Glucose Monitoring System are not impacted by the updates to the system algorithm and minor changes to the user interface and sensor delivery unit, such as adhesive sterilization method. It is anticipated that information collected will be submitted as a supplement to Premarket Approval Application (P050020) to the US Food and Drug Administration for approval to market this version of the system.

Conditions

  • Diabetes Mellitus

Interventions

  • FreeStyle Navigator Continuous Glucose Monitoring System Version 1.5Device

    This is not an interventional study. Subjects must maintain their own diabetes treatment regimen throughout the study duration.

Primary outcomes

What the sponsor says the trial is designed to measure.

No primary outcomes listed.

Locations

2 sites in 1 country. Site status is shown where the registry gives one.

  • Diablo Clinical Research

    Walnut Creek, California

  • Rainier Clinical Research

    Renton, Washington

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.